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• Sitbmandibular glandpeptide-T (SGP-T), a hepta- 
peptide with the sequence ofthreonine, aspartate, isoleucine, 
phenylalanine, glutamate, glycine, gfycine (TDIFEGG), was 
isolated from the Sitbmandibular glands of rats based on the 
ability of extracts of these glands to reduce the hypotension 
induced by bacterial lipopolysaccharide. SGP-T was also 
found to decrease the severity of the cardiovascular shock 
provoked by antigen administration to ovalbumin-sensitized 
rats. An analysis of the structure-activity relationship re 
vealed that three amino acids, phenylalanine, gluta 
mate,glycine (PEG), located in the carboxy terminal of SGP-T 
were sufficient to inhibit intestinal anaphylaxis in vitro. Inter 
estingly, the D-isomeric form of PEG (feG) did not inhibit 
anaphylaxis in the in vitro assay. However, both tripeptides, 
FEG and feG, significantly reduced anaphylactic hypotension 
and intestinal anaphylaxis in vivo. SGP-T may be a prototype 
of a family of small peplides that modulate the immune and 
smooth muscle reactions to severe inflammatory stress. SGP- T 
preferentially inhibits cardiovascular anaphylaxis, whereas 
feG exhibits a high degree of selectivity for inhibiting intesti 
nal anaphylaxis in vivo. (Biomed Rev 1998; 9: 101-106) 
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• Even though endocrine secretion from the salivary 
glands was described over 40 years ago, these glands are still 
primarily considered as accessory digestive organs that also 
have a primary role in the maintenance of oral health. Although 
this latter role is of utmost importance, as reduced exocrine 
salivary secretions may cause important and debilitating distur 
bances to oral homeostasis (1,2), a more subtle but nonetheless 
consequential ro le for the salivary glands in the regulation of the 
milieu interiew is now appreciated and accepted. A variety of 
studies, some of which are reviewed in this volume, attest to the 
importance of salivary endocrine secretions in modulating a 
variety of morphological, immunological and physiological 
functions that have an important impact on systemic health. 
Salivary endocrine secretions are involved in maintaining the 
structure and function of the digestive tract (3-5), mammary 
glands (6), liver (7-9), reproductive tract (10,11), and the immune 
system. Through the secretion of a variety of growth factors, 
salivary glands exert modulatory effects on lymphocyte (12,13), 
mast cell (14,15), neutrophil (16,17), and macrophage (18) 
functions. The submandibular glands (SMG) also regulate 
inflammatory reactions associated with the late-phase pulmonary 
inflammation induced by allergen in sensitized rats (19,20). 
Closely associated with the regulatory actions of salivary gland 
endocrine secretion and modulation of immune system function is 
the modulation of physiological functions by the salivary 
glands. By far the most intensely studied is the role that the 
salivary glands play in esophageal (21) and gastric ulcers (3,22) 





in the regulation of cardiovascular responses to endotoxic (23) 
and anaphylactic (24) shock. 
The purpose of this short review is to illustrate the importance of 
the salivary glands, and in particular some small peptides 
isolated from them, in the regulation of acute pathophysiologi-cal 
sequelae provoked by endotoxic and allergic reactions. 
REDUCTION OF ENDOTOXIC HYPOTENSION BY 
SALIVARY GLAND PEPTIDES 
• Several years ago, we found that removal of the SMG 
exacerbates the severity of the hypotension provoked by the 
intravenous administration of a bacterial endotoxin, lipopolysac- 
charide (LPS), to rats (25). After this observation we initiated a 
series of experiments to isolate and identify the antiendotoxic 
shock factors, and much to our surprise we were not dealing with 
any of the growth factors (molecular weight over 6 kD), but ra 
ther with material that had a molecular weight of less than 2 kD. 
Several SMG peptides were identified thatreduced the severity 
of endotoxic hypotension (23): the pentapeptide SGP-S, sequen 
ce of Ser-Gly-Glu-Gly-Val (SGEGV) and theheptapeptide SGP-T, 
sequenceofThr-Asp-Ile-Phe-Glu-Gly-Gly(TDIFEGG). Although 
the parent protein for these peptides was not isolated or identi 
fied, a Genbank search (26) identified these two sequences in a 
preprohormone found exclusively in the rat SMG. SGP-S is fo 
und closer to the amino terminal of this protein, submandibular 
rat 1 protein(SMRl)(27,28)whereasSGP-Tislocatedveryclose 
to the carboxy terminal. SMR1 isapreprohormonethatprovides 
several maturation peptides, an undeca-, a hexa- and a penta 
peptide, that are under multifactorial endocrine control and re 
leased both locally into the oral cavity and systemically (29,30). 
Sialadenectomized rats consistently exhibited a more severe 
hypotensive response to LPS than unoperated rats (25). With 
the unoperated rats, SGP-T at a dose of 100|ag/kg effectively 
prevented the characteristic LPS-induced drop in mean arterial 
blood pressure when given 90 or 30 min prior to LPS, as well as 
when administered 10 min after LPS injection. Compared with 
pre-LPS values, overall SGP-T reduced by 60% the decrease and 
the percent decrease in mean arterial blood pressure induced by 
LPS. With sialadenectomized rats, SGP-T inhibited endotoxin 
induced hypotension at doses as low as 1 tig/kg (18). This result 
implies that a sensitization of the SGP-T receptor occurs upon 
removal of the SMG. 
SGP-S, on the other hand, regardless of the treatment schedule, 
had no effect on the shock induced by endotoxin in unoperated 
rats. However, with sialadenectomized rats. SGP-S effectively 
reduced the severity of endotoxic hypotension by 3 8% relative 
to the untreated controls. Subsequent studies have 
concentrated exclusively on SGP-T, and SGP-S remains to be 
examined in other biological assays. 
INHIBITION OF IMMEDIATE HYPERSEMSITIVITY 
REACTIONS 
» Since salivary glands participate in the severity of 
pulmonary anaphylactic reactions (31). we decided to examine 
the effects of SGP-T on anaphylactic reactions. Several different 
anaphylactic models have been explored, and the results of 
these studies are briefly reviewed. 
• Intestinal anaphylaxis in vitro 
Using a classical anaphylactic model, the Schultz-Dale reaction, 
we found that SGP-T in vitro, at doses of 6.8 X 10'6M, inhibited by 
approximately 50% allergen-induced contractions of the jejunal 
segments obtained from ovalbumin-sensitized rats (Table 1). 
Subsequent structure activity relationship studies revealed that 
the tripeptide, PEG, located at the carboxy terminal ofSGP-Talso 
inhibited, toasimilarextent, intestinal anaphylaxis in the organ 
bath (32). In contrast, the D-isomeric form of PEG, the tripeptide 
feG, was inactive. 
• Intestinal anaphylaxis //; vivo 
SGP-T and the tripeptides were then evaluated for their ability to 
inhibit intestinal anaphylaxis in vivo (24,33). The intragastric 
administration of allergen to fasted, ovalbumin-sensitized Hooded 
Lister rats results in a disruption of the fasting pattern of 
gastrointestinal motility which is characterized by repeated oral-
to-aboral propagation of smooth muscle contractions (migrating 
myoelectric complexes, MMC) that exhibit a periodicity of 
~10min(34). Allergen disrupted this rhythmic pattern of myoe-
lectricity to replace it with a continuous apparently unorganized 
pattern of smooth muscle contractions, and invariably provoked 
diarrhea, a clinical sign of intestinal anaphylaxis. The disruption 
of MMC lasted for 30 to 60 min before the normal fasting MMC 
periodicity was reestablished. Intravenous SGP-T, FEG, and feG 
at doses of 100|ig/kg significantly reduced the allergen-provoked 
disruption of myoelectric activity and fewer rats developed 
diarrhea. Furthermore, the oral administration of feG at a dose of 
3 50ug/kg totally blocked the anaphylactic reaction. 
•         Anaphylactic hypotension 
Using ovalbumin-sensitized rats, SGP-T was administered 
intravenously at doses ranging from 35 to350ug/kg 10 min prior 
to intravenous injection of the antigen. In saline-treated rats, the 
anaphylaxis provoked-drop in blood pressure was reduced 
significantly, 60% to 70%, by intravenous SGP-T at doses of 35 
and 100|.ig/kg. Intravenous FEG and feG, at doses of 1 OOug/kg 
given 1 Omin prior to challenging the animal with antigen, reduced 
the anaphylactic hypotension by approximately 50% and 30%, 
respectively. A dose of 350ug/kg feG, given by gavage one 
hour before antigen challenge, reduced anaphylactic 
hypotension by more than 50% (32,33) (Table 1).   
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'MMCs, migrating myoelectric complexes; 2URE/OA, ratio of the contractile response of isolated rat jejunum to urecholine (URE) and 
ovalbumin (OA); 3mean ± SEM; 4iv. peptide administered intravenously; 5po, peptide administered into the stomach. 
  
• Multiple receptors for SGP-T and feG? 
The results presented above indicate that SGP-T, FEG, and feG 
are effective in reducing anaphylactic reactions and endotoxic 
hypotension. Nonetheless, it is apparent that the peptides were 
not equally effective in all assays. To highlight their differential 
effectiveness, the ratio of control to experimental (i.e. in presence 
of the peptides) response was determined for the various 
bioassays (Table 2). These calculations revealed that SGP-T 
was most effective in preventing anaphylactic hypotension and 
the anaphylaxis disruption of MMC. The tripeptide feG was a 
very potent inhibitor of intestinal anaphylaxis in vivo, and 
substantially less active in the other assays. The tripeptide FEG 
was generally less effective than SGP-T and feG when these 
peptides showed high activity, and FEG did not exhibit 
specificity for any particular reaction as it was equally effective in 
all assays. These data also indicate that the isolated jejunal 
segments are not predictive of biological activity in vivo, and 
the whole animal environment appears to provide an 
additional component to the actions of the peptides. The nature 
of these additional elements are presently unknown, but could 
involve actions on nerves or interactions with other endocrine 
hormones. SGP-T exerts arelatively rapid action, since in numerous 
assays the inhibitory effect was observed within 10 minutes of 
peptide administration, and orally administered feG effectively 
prevented cardiovascular anaphylaxis when given one hour 
before antigen challenge. Thus, the peptides may have one or 
more of the following characteristics: (/) a rapid mechanism of 
action that probably does not require tie novo protein synthesis, 
(//') prolonged receptor binding or long term deactivation of a 
cellular activation process or slow release from serum binding 
proteins, and (///') an absence in the stereospecificity of the 
receptor. Concerning this latter point, receptors are generally 
believed to exhibit stereoselective actions for their ligands 
although this constraint does not seem to apply to some peptides. 
Several D-isomeric forms of peptides have been shown to have 
greater activity than their L-isomeric congeners. These include: 
YYW1GIRK-NH2 in inhibitingneutroph.il infiltration in a 
thioglycolate-induced mouse peritonitis model (35), and 
acetyl-RRWWCR-NH2, an inhibitor of interleukin-8 (IL-8) in 
inducing neutrophil chemotaxis and binding of macrophage-
inhibitory protein-2(3 to neutrophils (36). 
• Mechanism of reducing anaphylaxis by the SGP-T 
andfeG 
To examine the effects of the peptides on mast cells, the 
mesentery was stained with 1 % safranine solution for 2 min, and 
then small sections were excised and mounted on slides (37). 
Fifty mast cells per slide were examined and categorized as 
degranulated if they had a disperse granular appearance or 
intact when the stained granules were restricted to a defined 
ovoid shape (Fig. 1). Unstimulated mast cells are generally ovoid in 
shape and their granules, stained with safranine, are localized and 
restricted to the interior of the cell. However, upon stimulation 
with antigen the mast cells take on a more diffuse appear- 
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'The 5-100 ratio depends upon whether feG was administered intravenously (ratio = 5) or orally (ratio = 100). 
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ance and granules are dispersed into the extracellular space. In 
rats treated with saline, 100 or 350 ug/kg of feG, 68.6%, 68.6%, 
and 50% of mast cells showed a degranulated appearance, 
respectively. There was no significant correlation found 
between the dose of feG given and the percentage of mast cells that 
were degranulated after anaphylaxis(p=0.524). 
The mechanism of action by which SGP-T and feG exert their 
effects remains unknown, but these peptides neither affect mast 
cell degranulation nor inhibit the actions of myoactive mediators 
of anaphylaxis on smooth muscle. An assay of rat mast cell 
protease II showed that the release of this enzyme from mast 
cells after antigen challenge was not significantly reduced by 
SGP-T (24), we were unable at present to find histological 
evidence that feG acted as a mast cell stabilizer. In regard to 
inhibition of the mediators of anaphylaxis, SGP-T did not 
antagonize the myogenic actions of serotonin, histamine or 
prostaglandin E2 (23), the principle mediators ofjejunal 
anaphylaxis in the rat (34). Other mechanisms must account for 
the inhibitory effect of SGP-T and the tripeptides FEG and feG 
on anaphylaxis. The possibility remains to be considered that 
these peptides inhibit the synthesized mediators such as platelet 
activating factor or leukotrienes, whose synthesis is activated 
when antigen binds to the IzE antibodies on mast cells. 
Nonetheless, other mecha- 
nisms may need to be considered. These include actions on the 
nervous system and modification of cell-cell interactions that 
participate in hypersensitivity reactions (38). 
CONCLUSION 
• With the exception of bradykinin, which is generated 
by kallikreins released from salivary gland and may act locally 
to modulate blood flow (39), it is generally believed that salivary 
glands exert their systemic morphological and immunological 
effects through the release of a variety of polypeptide growth 
factors (40,41). However, the present and other recent studies 
(27-30) illustrate that salivary glands are a source of small, mo 
lecular weight less than IkD, biologically active peptides that 
can exert effects in the peripheral circulation by very specific 
mechanisms. These observations will change the perspective 
by which we examine the role of the salivary glands in regula 
ting homeostatic responses (42). 
ACKNOWLEDGMENTS 
D The financial support of the Medical Research Council 


























Figure 1. Mesenleric mast cells stained with 1% safranine 30 min after injection oj antigen to u\'a/biimin-seiisili:ecl rt/ts  that 
were either pretreated with the 0.9% saline vehicle (A) or 350/.ig/kg of the tripeptic/e feG (B). Degranulation of the mast cells is 
seen in vehicle andpeptide-treated rats, x 815. 
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